CRISPR Therapeutics AG (CRSP)
57.08
-2.42
(-4.08%)
USD |
NASDAQ |
Aug 24, 16:00
57.64
+0.56
(+0.99%)
Pre-Market: 09:21
CRISPR Therapeutics Gross Profit Margin (Quarterly) : -337.8% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -337.8% |
| March 31, 2026 | -3.35K% |
| December 31, 2025 | -6.77K% |
| September 30, 2025 | -6.82K% |
| June 30, 2025 | -5.48K% |
| March 31, 2025 | -7.10K% |
| December 31, 2024 | 86.43% |
| September 30, 2024 | -2.55K% |
| June 30, 2024 | -10.92K% |
| March 31, 2024 | -10.18K% |
| December 31, 2023 | 87.62% |
| September 30, 2023 | |
| June 30, 2023 | 29.15% |
| March 31, 2023 | 52.76% |
| December 31, 2022 | -211.0K% |
| September 30, 2022 | -5.24K% |
| June 30, 2022 | -4.50K% |
| March 31, 2022 | -542.4% |
| December 31, 2021 | 51.46% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 85.37% |
| BeOne Medicines Ltd. | 87.80% |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| AC Immune SA | 0.00% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.76% |
| Return on Assets | -18.93% |
| Return on Invested Capital | -19.94% |
| Profit Margin (Quarterly) | -895.3% |
| Operating Margin (Quarterly) | -1.13K% |
| Return on Net Operating Assets | -181.9% |